GlassScriptPhysician profile
Wasima Masoodi
NPI 1275563017
$675.94
in general payments reported to CMS, 2019-2025
16 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.01 · 2020: $24.68 · 2021: $59.02 · 2022: $83.48 · 2023: $112 · 2024: $182 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $143.11 | 2021-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Abbott Laboratories | $138.90 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $82.16 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| Tandem Diabetes Care, INC. | $76.52 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $40.15 | 2022-2023 | Gvoke Hypopen |
| Abbvie INC. | $25.71 | 2025 | |
| Medtronic Minimed, INC. | $24.68 | 2020 | |
| Corcept Therapeutics | $20.91 | 2019 | |
| Merck Sharp & Dohme LLC | $19.74 | 2021 | |
| Pfizer INC. | $18.20 | 2021 | |
| Lifescan, INC. | $16.09 | 2019 | |
| Novo Nordisk INC | $15.91 | 2024 | Ozempic, Rybelsus |
| Sequel Med Tech, LLC | $14.85 | 2025 | Twiist |
| Amarin Pharma, INC. | $13.49 | 2019 | |
| Antares Pharma, INC. | $12.89 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wasima Masoodi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.